Sign In  |  Register  |  About San Rafael  |  Contact Us

San Rafael, CA
September 01, 2020 1:37pm
7-Day Forecast | Traffic

  • Search Hotels in San Rafael

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cardinal Health (NY: CAH )

116.13 +7.61 (+7.01%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cardinal Health

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Cardinal Health Inc. (NYSE: CAH) Climbs to New 52-Week High
Via Investor Brand Network
Earnings Preview: Cardinal Health
Via Benzinga
Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism?
An analyst sees the Satya Nadella-led company's earnings to be the key barometer for AI spending. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Here's How Much You Would Have Made Owning Cardinal Health Stock In The Last 5 Years
Via Benzinga
3 Top-Ranked Large-Caps To Buy For Growth
Large-cap stocks are frequently targeted among investors. They typically have greater stability and a proven track record, two reasons why they're beloved. 
Via Talk Markets
2023 Year-End Sector Review – Part 2
In this 2023 year-end sector review, we will take a look at what kind of year it was for healthcare, industrial, technology, materials, REITs, and utility sectors. Additionally, how is 2024 shaping up... 
Via Talk Markets
Dow Resumes Selloff, Set To Snap Win Streak
Stocks have resumed their trek lower in what has become an alarming trend to start 2024. 
Via Talk Markets
Topics Stocks
Exposures US Equities
What's Going On With Cardinal Health Shares Today?
Cardinal Health Inc (NYSE: CAH) shares are trading lower by around 4% after the company provided an update on its FY24 outlook and ongoing portfolio review. 
Via Benzinga
How Is The Market Feeling About Cardinal Health?
Via Benzinga
Will My Portfolio’s Top 3 Performing Stocks From 2023 Deliver Again in 2024?
This stock expert takes a look at his portfolio's top performing stocks from the last year. 
Via InvestorPlace
Here's How Much $1000 Invested In Cardinal Health 5 Years Ago Would Be Worth Today
Via Benzinga
$1000 Invested In Cardinal Health 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Best Performing Stocks In January Over The Last Two Decades (75%+ Win Rate)
January is generally one of the weakest months of the year for the stock market, but the following stocks have excelled in January over the last 15 years or more. 
Via Talk Markets
Wall Street's Top 10 Stock Calls This Week - Saturday, Dec. 16
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of Dec. 11-15. 
Via Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 No-Brainer Stocks to Buy in December
These are no-brainer stocks to buy regardless of whether we are in a bull or bear market. Strong tailwinds continue to push them forward. 
Via InvestorPlace
Becton Dickinson Recall Certain Infusion Pumps Due To Compatibility Issues With Cardinal Health's Monoject Syringes
Friday, the FDA said that Becton, Dicki 
Via Benzinga
How Is The Market Feeling About Cardinal Health?
Via Benzinga
Peering Into Cardinal Health's Recent Short Interest
Via Benzinga
Jim Cramer: Buy Shares Of This Personal Computer Giant, Wait For 'A Little Bit Of Pullback'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he would not buy CRISPR Therapeutics AG (NASDAQ: CRSP) stock "all the way up here. 
Via Benzinga
Jim Cramer Bullish On Boeing In Latest 'Lightning Round': 'This Is Their Year'
Cramer's optimism about Boeing follows his previous praise for the company in April 2023, when he referred to it as "really incredible." 
Via Benzinga
Teva Pharma is the way to play the re-rise of generic drugs
Generic and specialty pharmaceutical company, Teva Pharmaceutical's stock, has underperformed for years, but a potential spinoff may be a catalyst for growth 
Via MarketBeat
JP Morgan Maintains Neutral Rating for Cardinal Health: Here's What You Need To Know
Via Benzinga
Could Your Eye Drops Be Unsafe? FDA Flags Amazon For Distributing Risky Eye Products, Demands Immediate Action
Amazon.Com, Inc. (NASDAQ: AMZN) has received a  
Via Benzinga
Exposures Product Safety
Dividend Income Update October 2023
It’s dividend income update time. One of my favorite times of the month as I get to review my previous month of passive income received from my dividend income portfolio. 
Via Talk Markets
Royal Rule: Buy These 3 Dividend Aristocrats on Every. Single. Dip.
Choosing dividend aristocrats to buy becomes easy when you elect to buy the royalty of income-generating stocks. 
Via InvestorPlace
Cardinal Health Inc. (NYSE: CAH) Climbs to New 52-Week High
Via Investor Brand Network
Stock Market Rally Back In Force As Treasury Yields Plunge; Arista, Palantir Among Winners: Weekly Review
Bulls are back in control as the major indexes confirmed the uptrend this week. 
Via Investor's Business Daily
Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Cardinal Health Inc. (NYSE: CAH) Records 52-Week High Friday Morning
Via Investor Brand Network
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanRafael.com & California Media Partners, LLC. All rights reserved.